Pages that link to "Q35164747"
Jump to navigation
Jump to search
The following pages link to Clinically tested drugs for Alzheimer's disease (Q35164747):
Displaying 11 items.
- Microglial responses to amyloid beta peptide opsonization and indomethacin treatment. (Q24811635) (← links)
- Lessons from Microglia Aging for the Link between Inflammatory Bone Disorders and Alzheimer's Disease (Q28085613) (← links)
- A biomarker for severity of Alzheimer's disease: 1H-NMR resonances in cerebrospinal fluid correlate with performance in mini-mental-state-exam (Q34144542) (← links)
- Pharmacological characterization of DM232 (unifiram) and DM235 (sunifiram), new potent cognition enhancers. (Q34546584) (← links)
- Novel cholinesterase inhibitors as future effective drugs for the treatment of Alzheimer's disease (Q36349629) (← links)
- The Neuroprotective Effects of Ratanasampil on Oxidative Stress-Mediated Neuronal Damage in Human Neuronal SH-SY5Y Cells. (Q38865088) (← links)
- Coumarin derivatives bearing benzoheterocycle moiety: synthesis, cholinesterase inhibitory, and docking simulation study. (Q41506738) (← links)
- Aminopyridazines attenuate hippocampus-dependent behavioral deficits induced by human beta-amyloid in a murine model of neuroinflammation (Q45020586) (← links)
- Huperzia saururus, activity on synaptic transmission in the hippocampus. (Q51986673) (← links)
- Effect of Donepezil, Tacrine, Galantamine and Rivastigmine on Acetylcholinesterase Inhibition in Dugesia tigrina (Q60516601) (← links)
- Bojungikgi-Tang, a Traditional Herbal Formula, Exerts Neuroprotective Effects and Ameliorates Memory Impairments in Alzheimer's Disease-Like Experimental Models (Q60962004) (← links)